Companies › BTMD

BIOTE CORP (BTMD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001819253 · EDGAR filings · Updated 2026-07-27

BIOTE CORP (BTMD) has reported institutional ownership of 49.6%, with 84 institutional managers holding positions valued at $20.5M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-17 — Amended current report (8-K/A) filed
• 2026-06-16 — Insider transaction reported (Form 4)
• 2026-06-10 — Insider transaction reported (Form 4)
• 2026-06-10 — Insider transaction reported (Form 4)
• 2026-06-02 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BIOTE CORP has 84 institutional holders and institutional ownership of 49.6%.

Insider activity

Insiders reported 17 transactions (15 buys, 0 sells) across 6 reporting insiders, with a net reported value of $5.05M.

Data flags from SEC filings

Related companies

ACRIVON THERAPEUTICS INC (ACRV) · ALPHA TEKNOVA INC (TKNO) · Aligos Therapeutics Inc (ALGS) · Seres Therapeutics Inc (MCRB) · Neonc Technologies HLDGS (NTHI) · Grace Therapeutics Inc (GRCE)